Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TP53 | P04637 | 1/20 | 0.35 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.30 |
| ▸ | PSIP1 | O75475 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18270036 | 0.86 | LTA4H (0.35) | — | |
| SCHEMBL14787941 | 0.85 | LTA4H (0.36) | TP53KCNH2 | |
| SCHEMBL26404626 | 0.84 | SOAT2 (0.33) | — | |
| SCHEMBL28555187 | 0.83 | DNM1 (0.38) | TP53KCNH2 | |
| SCHEMBL28945192 | 0.83 | DNM1 (0.38) | TP53KCNH2 | |
| SCHEMBL4951520 | 0.80 | TP53 (0.38) | TP53PSIP1 | |
| SCHEMBL29025756 | 0.80 | EPHX2 (0.34) | — | |
| SCHEMBL9317971 | 0.75 | TP53 (0.43) | TP53 | |
| SCHEMBL5818573 | 0.75 | TP53 (0.38) | TP53PSIP1 | |
| SCHEMBL5289246 | 0.73 | TP53 (0.36) | TP53PSIP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117603160-A | Synthesis method of high-purity tebuthiuron | 山东华阳农药化工集团有限公司 | 2024-02-27 | — | — | CN | claimed |
| CN-117603160-A | Synthesis method of high-purity tebuthiuron | 山东华阳农药化工集团有限公司 | 2024-02-27 | — | — | CN | disclosed |
| US-20170369418-A1 | POLYMERIZABLE POLAR COMPOUND, LIQUID CRYSTAL COMPOSITION, AND LIQUID CRYSTAL DISPLAY ELEMENT | JNC CORPORATION (JP) | 2017-12-28 | — | — | US | disclosed |
| US-20140315956-A1 | SMALL MOLECULE INHIBITORS OF IL-6 AND USES THEREOF | NATIONWIDE CHILDREN'S HOSPITAL (US) | 2014-10-23 | — | — | US | disclosed |
| US-20140315956-A1 | SMALL MOLECULE INHIBITORS OF IL-6 AND USES THEREOF | NATIONWIDE CHILDREN'S HOSPITAL (US) | 2014-10-23 | — | — | US | disclosed |
| WO-2013019690-A1 | SMALL MOLECULE INHIBITORS OF IL-6 AND USES THEREOF | THE OHIO STATE UNIVERSITY (US) | 2013-02-07 | — | — | WO | disclosed |
| EP-0750028-A2 | Alkenylcyclohexane derivatives, liquid crystal composition and liquid crystal display element | Chisso Corporation (JP) | 1996-12-27 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140315956-A1 | SMALL MOLECULE INHIBITORS OF IL-6 AND USES THEREOF | IL6, STAT3, JAK2 | TP53 343/4885KCNH2 3997/4885PSIP1 2234/4885 |
| US-20170369418-A1 | POLYMERIZABLE POLAR COMPOUND, LIQUID CRYSTAL COMPOSITION, AND LIQUID CRYSTAL DISPLAY ELEMENT | SP1, SPIN1, SAV1 | TP53 1968/4885KCNH2 373/4885PSIP1 367/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.